Table 3.
Endoscopic activity | Inactive | Mild | Moderate | High | P value |
---|---|---|---|---|---|
(0–3) | (4–10) | (11–19) | (≥20) | ||
Number of patients | 39 | 51 | 14 | 5 | |
Number of patients FC (μg/g) | 39 | 51 | 14 | 5 | <0.001 |
197.3 (99.7–5628) | 730 (254.4–1110.1) | 1017.2 (488.9–1455.3) | 2055.7 (818.2–4038.5) | ||
Number of patients ESR (mm/h) | 35 | 46 | 13 | 5 | <0.001 |
12 (6–23) | 17.5 (11.0–37.5) | 44 (34–76) | 28 (12–104) | ||
Number of patients CRP (mg/L) | 39 | 51 | 14 | 5 | <0.001 |
4.9 (1.7–25.3) | 19.6 (9.1–47.7) | 49.3 (12.0–60.9) | 47.8 (27.5–125.6) | ||
Number of patients CDAI | 37 | 47 | 14 | 5 | 0.052 |
126 (68–217) | 175 (107–233) | 253 (113.2–330.0) | 350 (108–489.5) |
Median interquartile range (IQR) for continuous variables; SES-CD, simple endoscopic score for Crohn’s disease; FC, faecal calprotectin; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; CDAI, Crohn’s disease activity index.